A citation-based method for searching scientific literature

Han Xiao, Marian J Killip, Peter Staeheli, Richard E Randall, David Jackson. J Virol 2013
Times Cited: 69







List of co-cited articles
936 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein.
Benjamin Mänz, Dominik Dornfeld, Veronika Götz, Roland Zell, Petra Zimmermann, Otto Haller, Georg Kochs, Martin Schwemmle. PLoS Pathog 2013
101
49

The viral nucleoprotein determines Mx sensitivity of influenza A viruses.
Petra Zimmermann, Benjamin Mänz, Otto Haller, Martin Schwemmle, Georg Kochs. J Virol 2011
118
49


Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.
Jan Dittmann, Silke Stertz, Daniel Grimm, John Steel, Adolfo García-Sastre, Otto Haller, Georg Kochs. J Virol 2008
108
28

Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function.
Song Gao, Alexander von der Malsburg, Alexej Dick, Katja Faelber, Gunnar F Schröder, Otto Haller, Georg Kochs, Oliver Daumke. Immunity 2011
138
27

Mx GTPases: dynamin-like antiviral machines of innate immunity.
Otto Haller, Peter Staeheli, Martin Schwemmle, Georg Kochs. Trends Microbiol 2015
215
27

Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells.
Shannon R Matzinger, Timothy D Carroll, Joseph C Dutra, Zhong-Min Ma, Christopher J Miller. J Virol 2013
27
62


Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Caroline Goujon, Olivier Moncorgé, Hélène Bauby, Tomas Doyle, Christopher C Ward, Torsten Schaller, Stéphane Hué, Wendy S Barclay, Reiner Schulz, Michael H Malim. Nature 2013
354
24

Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.
Georg Kochs, Christian Janzen, Heinz Hohenberg, Otto Haller. Proc Natl Acad Sci U S A 2002
138
24

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
462
23

The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
David Riegger, Rong Hai, Dominik Dornfeld, Benjamin Mänz, Victor Leyva-Grado, Maria T Sánchez-Aparicio, Randy A Albrecht, Peter Palese, Otto Haller, Martin Schwemmle,[...]. J Virol 2015
34
47

Structural basis of oligomerization in the stalk region of dynamin-like MxA.
Song Gao, Alexander von der Malsburg, Susann Paeschke, Joachim Behlke, Otto Haller, Georg Kochs, Oliver Daumke. Nature 2010
170
21

Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.
Judith Verhelst, Eef Parthoens, Bert Schepens, Walter Fiers, Xavier Saelens. J Virol 2012
100
21

MX2 is an interferon-induced inhibitor of HIV-1 infection.
Melissa Kane, Shalini S Yadav, Julia Bitzegeio, Sebla B Kutluay, Trinity Zang, Sam J Wilson, John W Schoggins, Charles M Rice, Masahiro Yamashita, Theodora Hatziioannou,[...]. Nature 2013
307
21

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
814
21


Mx proteins: antiviral gatekeepers that restrain the uninvited.
Judith Verhelst, Paco Hulpiau, Xavier Saelens. Microbiol Mol Biol Rev 2013
134
21

Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.
Kadir Turan, Masaki Mibayashi, Kenji Sugiyama, Shoko Saito, Akiko Numajiri, Kyosuke Nagata. Nucleic Acids Res 2004
118
20


The interferon-inducible MxB protein inhibits HIV-1 infection.
Zhenlong Liu, Qinghua Pan, Shilei Ding, Jin Qian, Fengwen Xu, Jinming Zhou, Shan Cen, Fei Guo, Chen Liang. Cell Host Microbe 2013
216
18


A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
18

Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA.
Patrick S Mitchell, Corinna Patzina, Michael Emerman, Otto Haller, Harmit S Malik, Georg Kochs. Cell Host Microbe 2012
93
17

Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes.
Mike Reichelt, Silke Stertz, Jacomine Krijnse-Locker, Otto Haller, Georg Kochs. Traffic 2004
80
17


cDNA structures and regulation of two interferon-induced human Mx proteins.
M Aebi, J Fäh, N Hurt, C E Samuel, D Thomis, L Bazzigher, J Pavlovic, O Haller, P Staeheli. Mol Cell Biol 1989
281
17

Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import.
Veronika Götz, Linda Magar, Dominik Dornfeld, Sebastian Giese, Anne Pohlmann, Dirk Höper, Byung-Whi Kong, David A Jans, Martin Beer, Otto Haller,[...]. Sci Rep 2016
81
17

Interferon-stimulated genes: a complex web of host defenses.
William M Schneider, Meike Dittmann Chevillotte, Charles M Rice. Annu Rev Immunol 2014
15

An evolutionary perspective on the broad antiviral specificity of MxA.
Patrick S Mitchell, Michael Emerman, Harmit S Malik. Curr Opin Microbiol 2013
42
23


Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.
Hiroki Kato, Osamu Takeuchi, Shintaro Sato, Mitsutoshi Yoneyama, Masahiro Yamamoto, Kosuke Matsui, Satoshi Uematsu, Andreas Jung, Taro Kawai, Ken J Ishii,[...]. Nature 2006
14

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.
Markus Mordstein, Georg Kochs, Laure Dumoutier, Jean-Christophe Renauld, Søren R Paludan, Kevin Klucher, Peter Staeheli. PLoS Pathog 2008
237
14

Host and viral determinants of Mx2 antiretroviral activity.
Idoia Busnadiego, Melissa Kane, Suzannah J Rihn, Hannah F Preugschas, Joseph Hughes, Daniel Blanco-Melo, Victoria P Strouvelle, Trinity M Zang, Brian J Willett, Chris Boutell,[...]. J Virol 2014
100
14

RIG-I detects viral genomic RNA during negative-strand RNA virus infection.
Jan Rehwinkel, Choon Ping Tan, Delphine Goubau, Oliver Schulz, Andreas Pichlmair, Katja Bier, Nicole Robb, Frank Vreede, Wendy Barclay, Ervin Fodor,[...]. Cell 2010
380
14

The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum.
Molly A Accola, Bing Huang, Azzah Al Masri, Mark A McNiven. J Biol Chem 2002
106
13

The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein.
Zsuzsanna T Varga, Irene Ramos, Rong Hai, Mirco Schmolke, Adolfo García-Sastre, Ana Fernandez-Sesma, Peter Palese. PLoS Pathog 2011
159
13

Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I.
Michaela Ulrike Gack, Randy Allen Albrecht, Tomohiko Urano, Kyung-Soo Inn, I-Chueh Huang, Elena Carnero, Michael Farzan, Satoshi Inoue, Jae Ung Jung, Adolfo García-Sastre. Cell Host Microbe 2009
547
13


Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity.
Otto Haller, Song Gao, Alexander von der Malsburg, Oliver Daumke, Georg Kochs. J Biol Chem 2010
70
13

MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen.
Ning Li, Lei Zhang, Liangwei Chen, Wenfeng Feng, Yinfeng Xu, Feng Chen, Xiaohong Liu, Zhi Chen, Wei Liu. Hepatology 2012
53
16

Inhibition of a large double-stranded DNA virus by MxA protein.
Christopher L Netherton, Jennifer Simpson, Otto Haller, Thomas E Wileman, Haru-Hisa Takamatsu, Paul Monaghan, Geraldine Taylor. J Virol 2009
47
19

Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.
Dirk Holzinger, Carl Jorns, Silke Stertz, Stéphanie Boisson-Dupuis, Robert Thimme, Manfred Weidmann, Jean-Laurent Casanova, Otto Haller, Georg Kochs. J Virol 2007
158
13

Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation.
P Staeheli, R Grob, E Meier, J G Sutcliffe, O Haller. Mol Cell Biol 1988
224
13

Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Caroline Goujon, Olivier Moncorgé, Hélène Bauby, Tomas Doyle, Wendy S Barclay, Michael H Malim. J Virol 2014
58
15

MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1.
Thomas Fricke, Tommy E White, Bianca Schulte, Daniel A de Souza Aranha Vieira, Adarsh Dharan, Edward M Campbell, Alberto Brandariz-Nuñez, Felipe Diaz-Griffero. Retrovirology 2014
110
13

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.
Andreas Pichlmair, Oliver Schulz, Choon Ping Tan, Tanja I Näslund, Peter Liljeström, Friedemann Weber, Caetano Reis e Sousa. Science 2006
13

Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells.
Ronan Le Goffic, Julien Pothlichet, Damien Vitour, Takashi Fujita, Eliane Meurs, Michel Chignard, Mustapha Si-Tahar. J Immunol 2007
278
13

TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.
Andrea Di Pietro, Anna Kajaste-Rudnitski, Alexandra Oteiza, Lucia Nicora, Greg J Towers, Nadir Mechti, Elisa Vicenzi. J Virol 2013
125
13

Innate immunity to influenza virus infection.
Akiko Iwasaki, Padmini S Pillai. Nat Rev Immunol 2014
487
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.